Total Payments
$5,369
2024 Payments
$777.77
Companies
38
Transactions
326
Medicare Patients
5,703
Medicare Billing
$444,228
Payment Breakdown by Category
Food & Beverage$5,269 (98.1%)
Other$86.63 (1.6%)
Education$13.92 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,269 | 323 | 98.1% |
| Debt forgiveness | $86.63 | 1 | 1.6% |
| Education | $13.92 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $824.15 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $768.30 | 31 | $0 (2024) |
| ABBVIE INC. | $688.95 | 31 | $0 (2024) |
| Lilly USA, LLC | $388.84 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $304.46 | 22 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $245.11 | 33 | $0 (2019) |
| Novo Nordisk Inc | $212.91 | 13 | $0 (2024) |
| Amgen Inc. | $209.42 | 13 | $0 (2022) |
| Astellas Pharma US Inc | $163.93 | 9 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $160.78 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.77 | 36 | AstraZeneca Pharmaceuticals LP ($192.79) |
| 2023 | $612.13 | 30 | GlaxoSmithKline, LLC. ($165.95) |
| 2022 | $916.05 | 37 | ABBVIE INC. ($251.25) |
| 2021 | $904.84 | 54 | AbbVie Inc. ($217.61) |
| 2020 | $428.05 | 23 | AstraZeneca Pharmaceuticals LP ($126.78) |
| 2019 | $317.73 | 26 | Lilly USA, LLC ($63.09) |
| 2018 | $603.78 | 52 | Sunovion Pharmaceuticals Inc. ($172.75) |
| 2017 | $809.10 | 68 | GlaxoSmithKline, LLC. ($145.24) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINE | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Respiratory | ||||||
| 05/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: PSYCHIATRY | ||||||
| 05/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Neuropsychiatry | ||||||
| 05/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,164 | 1,915 | $250,112 | $95,343 |
| 2022 | 17 | 1,283 | 2,044 | $264,652 | $105,492 |
| 2021 | 19 | 1,409 | 2,511 | $336,755 | $125,404 |
| 2020 | 28 | 1,847 | 4,446 | $390,937 | $117,989 |
Total Patients
5,703
Total Services
10,916
Medicare Billing
$444,228
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 248 | 459 | $85,374 | $29,420 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 252 | $79,128 | $23,294 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $28,800 | $22,802 | 79.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $5,543 | $3,722 | 67.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 171 | 324 | $8,835 | $3,084 | 34.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 66 | $8,118 | $2,719 | 33.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,774 | $1,783 | 37.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $1,638 | $1,605 | 98.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 30 | $10,618 | $1,478 | 13.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 62 | 63 | $2,331 | $1,375 | 59.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 63 | $1,185 | $1,161 | 98.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,001 | $980.98 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 85 | $6,205 | $909.90 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $559.00 | $547.82 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 49 | 61 | $2,433 | $208.01 | 8.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 224 | $2,632 | $165.87 | 6.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 13 | 14 | $938.00 | $85.54 | 9.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 435 | $80,910 | $28,520 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 305 | $95,770 | $28,261 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 188 | 188 | $29,432 | $24,587 | 83.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 39 | 39 | $9,135 | $6,541 | 71.6% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 23 | 23 | $4,257 | $4,197 | 98.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 185 | 361 | $9,058 | $3,460 | 38.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 43 | 52 | $6,396 | $2,185 | 34.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 72 | 77 | $2,819 | $1,616 | 57.3% |
About Dr. Jonathan Binder, MD
Dr. Jonathan Binder, MD is a Family Medicine healthcare provider based in Casper, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841214954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Binder, MD has received a total of $5,369 in payments from pharmaceutical and medical device companies, with $777.77 received in 2024. These payments were reported across 326 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,269).
As a Medicare-enrolled provider, Binder has provided services to 5,703 Medicare beneficiaries, totaling 10,916 services with total Medicare billing of $444,228. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Casper, WY
- Active Since 07/26/2006
- Last Updated 08/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841214954
Products in Payments
- TRELEGY ELLIPTA (Drug) $531.51
- FARXIGA (Drug) $501.56
- UBRELVY (Drug) $347.74
- VRAYLAR (Drug) $201.80
- JANUVIA (Drug) $167.10
- BREZTRI (Drug) $166.66
- REXULTI (Drug) $150.96
- LONHALA MAGNAIR (Drug) $145.01
- TOUJEO (Drug) $130.30
- JARDIANCE (Drug) $126.18
- EMGALITY (Drug) $121.79
- QULIPTA (Drug) $116.65
- ELIQUIS (Drug) $113.56
- Prolia (Biological) $113.26
- Ozempic (Drug) $102.10
- Aimovig (Biological) $96.16
- Utibron (Drug) $87.67
- BELSOMRA (Drug) $86.78
- ENTRESTO (Drug) $83.86
- TRULICITY (Drug) $80.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Casper
Dr. Joseph Schoeber, M.d, M.D
Family Medicine — Payments: $197,031
Family Medicine $197,031
Dr. Eric Lawrence, Do, DO
Family Medicine — Payments: $8,352
Family Medicine $8,352
Dr. Karlynn Sievers, Md, MD
Family Medicine — Payments: $8,266
Family Medicine $8,266
Joseph Mickelson, Md, MD
Family Medicine — Payments: $7,239
Family Medicine $7,239
Louis Roussalis, M.d, M.D
Family Medicine — Payments: $5,443
Family Medicine $5,443
Sherrill Fox, M.d, M.D
Family Medicine — Payments: $4,911
Family Medicine $4,911